Encompass Health insider plans 18,869-share stock sale

Rhea-AI Filing Summary

Encompass Health Corporation insider Douglas Coltharp filed to potentially sell 18,869 shares of common stock through UBS Financial Services Inc. The proposed sale, tied to RSA vesting events dated January and February 2025, has an aggregate market value of $2,365,700.88. Encompass Health reports 98,653,384 shares of common stock outstanding, listed on the NYSE. Over the past three months, Coltharp previously sold 27,694 shares of common stock on May 15, 2026 for $2,958,629.

Key Figures

Proposed shares to be sold: 18,869 shares Aggregate market value of proposed sale: $2,365,700.88 Shares outstanding: 98,653,384 shares +2 more

5 metrics

Proposed shares to be sold 18,869 shares Common stock proposed for sale by Douglas Coltharp under Form 144

Aggregate market value of proposed sale $2,365,700.88 Value of 18,869 Encompass Health common shares

Shares outstanding 98,653,384 shares Encompass Health common stock outstanding as reported

Shares sold in past 3 months 27,694 shares Common stock sold on May 15, 2026 by Douglas Coltharp

Value of prior sale $2,958,629 Proceeds from 27,694-share sale on May 15, 2026

Key Terms

Form 144, RSA Vesting, aggregate market value

3 terms

Form 144 regulatory

"Douglas Coltharp filed to potentially sell shares under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSA Vesting financial

"The proposed sale is tied to RSA Vesting events in 2025"

aggregate market value financial

"The proposed sale has an aggregate market value of $2,365,700.88"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Encompass Health (EHC) disclose in this Form 144 filing?

The filing discloses a planned sale of 18,869 shares of Encompass Health common stock by insider Douglas Coltharp, related to restricted stock award vesting events in early 2025, with an indicated value of $2,365,700.88.

How many Encompass Health (EHC) shares are proposed to be sold and at what value?

Douglas Coltharp proposes to sell 18,869 shares of Encompass Health common stock, with an aggregate market value listed as $2,365,700.88. These shares arise from multiple RSA vesting dates in January and February 2025.

What prior share sales by Douglas Coltharp are reported for Encompass Health (EHC)?

Over the past three months, Douglas Coltharp is reported to have sold 27,694 shares of Encompass Health common stock on May 15, 2026, for total proceeds of $2,958,629, as part of the Form 144 disclosure history.

How large is Encompass Health (EHC) relative to this Form 144 sale?

Encompass Health has 98,653,384 shares of common stock outstanding. The proposed sale of 18,869 shares by Douglas Coltharp represents a small fraction of this total share count as reported in the filing.

On which exchange are Encompass Health (EHC) shares listed in this filing?

The filing lists Encompass Health common stock as traded on the NYSE. The proposed 18,869-share sale by Douglas Coltharp would therefore involve NYSE-listed common stock of Encompass Health Corporation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 05:11 PM Accepted by SEC EDGAR 08/10/2026 - 05:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001186879
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Encompass Health Corporation
SEC File Number	001-10315
Address of Issuer	9001 Liberty Parkway Birmingham ALABAMA 35242
Phone	205-967-7116
Name of Person for Whose Account the Securities are To Be Sold	Douglas Coltharp
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	18869	2365700.88	98653384	08/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/01/2025	RSA Vesting	Encompass Health Corporation			7075	08/10/2026	N/A
Common Stock	01/01/2025	RSA Vesting	Encompass Health Corporation			8307	08/10/2026	N/A
Common Stock	02/23/2025	RSA Vesting	Encompass Health Corporation			1161	08/10/2026	N/A
Common Stock	02/25/2025	RSA Vesting	Encompass Health Corporation			1353	08/10/2026	N/A
Common Stock	02/28/2025	RSA Vesting	Encompass Health Corporation			973	08/10/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Douglas Coltharp 2736 Abingdon Road Mountain Brook AL 35243	Common Stock	05/15/2026	27694	2958629

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Douglas Coltharp
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)